2 Mar 2023
Biocatalysts Ltd launch Nuclease for the growing precision fermentation market
Nuclease 46L has been designed specifically as a cost-effective solution for the elimination of nucleic acids in a wide range of biotechnology applications.
27 Feb 2023
BRAIN Biotech AG to build an international multi-niche enzyme and food ingredients champion
With the enzyme activities of the group focusing on food, beverage and healthcare, combined with BRAIN Biotech's strong scientific roots, the Group are well positioned to service global megatrends from the production of better and healthier foods to sustainable industrialisation.
16 Jan 2023
BRAIN Biotech AG reports record figures in fiscal year 2021/22
Despite a challenging geopolitical environment, BRAIN Biotech announce strong sales laying the foundations for ongoing future dynamic growth.
18 Nov 2022
Biocatalysts awarded in Top 10 Synthetic Biology Companies 2022 by Life Sciences Review!
We're very pleased to receive this esteemed award from Life Sciences Review in their annual listing of 10 companies that are at the forefront of providing Synthetic Biology solutions and transforming businesses.
25 Jul 2022
Precision Fermentation – a bio-based route to alternative protein
Nutrition in industrialised countries will move away from meat and dairy consumption towards alternative sources of protein and foods. These will rely on plants, microorganisms and cell cultures. Biotechnology will be the key enabler. This is where we come in.
14 Oct 2021
Biocatalysts Ltd Announce Plans for Further Investment for Second 10m³ Fermenter in Cardiff
The introduction of a second 10m³ fermenter enables Biocatalysts Ltd.’s manufacturing site in Cardiff to act as a pilot plant for medium-scale production and optimised tech-transfer for larger industrial scale fermentation.
Novel enzyme used in carbohydrate modification produced in partnership with sugar reduction company.
Working in close partnership we were able to rapidly scale up their process to produce the enzyme at commercial volumes enabling them to reduce the time to market for their unique offering into this exciting fast-moving sector.
11 Aug 2021
Project Completion & Successful Commissioning of Biocatalysts Ltd's New Enzyme Manufacturing Facility
Operations Director, Craig Galeozzie provides a final update following the successful project completion and commissioning of the new state-or-the-art enzyme manufacturing facility.
13 May 2021
Biocatalysts Ltd First Commercial Production in New Enzyme Manufacturing Facility
Key milestone achieved with the first product fermented and processed in the state-of-the-art enzyme manufacturing facility is delivered to the customer.
Introducing a NEW Expression Host – Yarrowia lipolytica
Expression strain developments increase Biocatalysts' enzyme development and manufacture service offering
4 Nov 2020
Winners of Prestigious IChemE Global Food & Drink Award 2020
IChemE have selected Biocatalysts Ltd in partnership with University College London (UCL) as the winners of the prestigious IChemE Global Food & Drink Award 2020, for our submission – Ultra Scale-Down Accelerates Industrial Enzyme Manufacture.
Partnering with a Global Pharmaceutical Company for Large Scale Enzyme Manufacturing
A large pharmaceutical company needed an enzyme manufacturing partner to develop their enzymes from lab to commercial scales.